×

Cramer's Mad Dash: GW Pharma jumps

9:22 AM ET Tue, 15 Sept 2015

Jim Cramer explains why he is keeping an eye on shares of GW Pharma after Phase II trials show promising results using marijuana to treat schizophrenia. Also Cramer is watching Kimberly-Clark after an upgrade.